X-ray powder diffraction data for 12 drugs in current use

Journal of Chemical and Engineering Data

Volumn 45, Issue 6, 2000, Pages 1001-1006

  Koundourellis, John E ^a   Malliou, Eleftheria T ^a   Sullivan, R A L ^b   Chapman, B ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF BATH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; CHLORINE COMPOUNDS; CRYSTAL LATTICES; CRYSTALLINE MATERIALS; MOLECULAR STRUCTURE; RHEOLOGY; SULFUR COMPOUNDS; SUSPENSIONS (FLUIDS); X RAY POWDER DIFFRACTION;

BIOAVAILABILITY;

DRUG PRODUCTS;

EID: 0034319571     PISSN: 00219568     EISSN: None     Source Type: Journal    
DOI: 10.1021/je0001025     Document Type: Article

References (15)

1. Hanawalt, J. D.; Rinn, H. W. Identification of Crystalline Materials - Classification and Use of X-ray Diffraction Patterns. Powder Diffr. 1986, 1, 2-6.
2. Koundourellis, J. E.; Malliou, E. T.; Sullivan, R. A. L.; Chapman, B. X-ray Characterization of 12 Vasodilators in Current Use. J. Chem. Eng. Data 1999, 44 (4), 656-660.
3. United States Pharmacopeia XXII and National Formulary XVII, 1990, pp 1621-1623.
4. Phadnis, N. V.; Caratur, R. K.; Suryanarayanan, R. Identification of drugs in pharmaceutical dosage forms by X-ray powder defraction. J. Pharm. Biomed. Anal. 1997, 15, 929-943.
5. Doff, D. H.; Brownen, F. L.; Corrigan, O. I. Determination of α-Impurities in the β-Polymorph of Inosine Using Infrared Spectroscopy and X-ray Powder Diffraction. Analyst 1986, 111, 179-182.
6. Bartolomei, M.; Ramusino, C. M.; Ghett, P. Solid-state investigation of fluocinolone acetonide. J. Pharm. Biomed. Anal. 1997, 15, 1813-1820.
7. Matsunage, H.; Eguchi, T.; Nishijima, K.; Enomoto, T.; Sasaoki, K.; Nakamura, N. Solid-state characterization of candesartan cilexetil (TCV-116): Crystal structure and molecular mobility. Chem. Pharm. Bull. 1999, 47 (2), 182-186.
8. Hassan, M. A.; Sheikh-Salem, M.; Sallam, E.; Al-Hindawi, M. K. Preparation and characterization of a new polymorphic form and a solvate of glibenclamide. Acta Pharm. Hung. 1007, 67, 81-88.
9. Nichols, G.; Frampton, C. S. Physicochemical Characterization of the orthorhombic polymorph of paracetamol crystallized from solution. J. Pharm. Sci. 1998, 87, 684-693.
10. DiMartino, P.; Confiant, P.; Drache, M.; Huvenne, J. P.; Guyot-Hermann, A. M. Preparation and physical characterization of forms II and III of paracetamol. J. Therm. Anal. 1997, 48, 447-458.
11. Liebenberg, W.; de Villiers, M. M.; Wurster, D. E.; Swanepoel, E.; Dekker, T. G.; Lotter, A. P. The effect of polymorphism comparison and dissolution properties of chemically equivalent oxytetracycline hydrochloride powders. Drug Dev. Ind. Pharm. 1999, 25 (9), 1027-1033.
12. Elks, J.; Ganellin, G. R. Dictionary of Drugs, Chemicals Data, Structures and Bibliographies; Chapman and Hall Ltd.: London, 1990.
13. Moffat, A. C., Ed. Clarke's Isolation and Identification of Drugs; The Pharmaceutical Press: London, 1986.
14. British Pharmacopoeia; London, 1993.
15. Klug and Alexander. X-ray diffraction procedures, 2nd ed.; Wiley & Son: New York, 1974; p 372.